CRISPR/Cas9 Gene-modification Platform of ELANE Mutations in iPSCs and HSPCs of Severe Congenital Neutropenia Patients

Klin Padiatr 2019; 231(03): 167
DOI: 10.1055/s-0039-1687168

Abstracts

Georg Thieme Verlag KG Stuttgart · New York

M Nasri

¹Department of Oncology, Hematology, Immunology, Rheumatology, and Pulmonology, University Hospital Tuebingen, Tübingen, Germany

,

B Dannenmann

¹Department of Oncology, Hematology, Immunology, Rheumatology, and Pulmonology, University Hospital Tuebingen, Tübingen, Germany

,

M Ritter

¹Department of Oncology, Hematology, Immunology, Rheumatology, and Pulmonology, University Hospital Tuebingen, Tübingen, Germany

,

P Mir

¹Department of Oncology, Hematology, Immunology, Rheumatology, and Pulmonology, University Hospital Tuebingen, Tübingen, Germany

,

Y Xu

¹Department of Oncology, Hematology, Immunology, Rheumatology, and Pulmonology, University Hospital Tuebingen, Tübingen, Germany

,

M Klimiankou

¹Department of Oncology, Hematology, Immunology, Rheumatology, and Pulmonology, University Hospital Tuebingen, Tübingen, Germany

,

C Zeidler

²Hematology/Oncology, SCNER, Hannover Medical School, Hannover, Germany

,

L Kanz

¹Department of Oncology, Hematology, Immunology, Rheumatology, and Pulmonology, University Hospital Tuebingen, Tübingen, Germany

,

K Welte

³The University Children's Hospital Tuebingen, Tuebingen, Germany

,

J Skokowa

¹Department of Oncology, Hematology, Immunology, Rheumatology, and Pulmonology, University Hospital Tuebingen, Tübingen, Germany